RPg Family Wealth Advisory’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-38
Closed -$5.2K 134
2022
Q1
$5.2K Buy
+38
New +$5.3K ﹤0.01% 311
2017
Q4
Sell
-152
Closed -$14.2K 278
2017
Q3
$14.2K Buy
+152
New +$16.1K 0.01% 243
2017
Q1
Sell
-181
Closed -$16.6K 291
2016
Q4
$16.6K Hold
181
0.01% 207
2016
Q3
$15.3K Hold
181
0.01% 205
2016
Q2
$14.7K Hold
181
0.01% 214
2016
Q1
$12.9K Buy
+181
New +$12.1K 0.01% 229

Other funds holding DGX

RPg Family Wealth Advisory's DGX Position: Q2 2022 in Review

RPg Family Wealth Advisory sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 38 shares — an estimated $5.2K sold.

RPg Family Wealth Advisory first reported a position in DGX in Q1 2016 and held it in 6 quarters. The position peaked at $16.6K in Q4 2016. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • RPg Family Wealth Advisory reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 38 Quest Diagnostics shares in Q2 2022, an estimated $5.2K.
  • RPg Family Wealth Advisory first reported a position in Quest Diagnostics in Q1 2016 and held it in 6 quarters.
  • RPg Family Wealth Advisory's Quest Diagnostics position peaked at $16.6K in Q4 2016.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on RPg Family Wealth Advisory's 13F filing for Q2 2022, filed 12 Aug 2022.